These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10797612

  • 21. Negative regulation of oligodendrocyte differentiation by galactosphingolipids.
    Bansal R, Winkler S, Bheddah S.
    J Neurosci; 1999 Sep 15; 19(18):7913-24. PubMed ID: 10479693
    [Abstract] [Full Text] [Related]

  • 22. Myelination and motor coordination are increased in transferrin transgenic mice.
    Saleh MC, Espinosa de los Monteros A, de Arriba Zerpa GA, Fontaine I, Piaud O, Djordjijevic D, Baroukh N, Garcia Otin AL, Ortiz E, Lewis S, Fiette L, Santambrogio P, Belzung C, Connor JR, de Vellis J, Pasquini JM, Zakin MM, Baron B, Guillou F.
    J Neurosci Res; 2003 Jun 01; 72(5):587-94. PubMed ID: 12749023
    [Abstract] [Full Text] [Related]

  • 23. Oligodendrocyte development and differentiation in the rumpshaker mutation.
    Fanarraga ML, Sommer IU, Griffiths IR, Montague P, Groome NP, Nave KA, Schneider A, Brophy PJ, Kennedy PG.
    Glia; 1993 Oct 01; 9(2):146-56. PubMed ID: 7503954
    [Abstract] [Full Text] [Related]

  • 24. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
    Saadat L, Dupree JL, Kilkus J, Han X, Traka M, Proia RL, Dawson G, Popko B.
    Glia; 2010 Mar 01; 58(4):391-8. PubMed ID: 19705459
    [Abstract] [Full Text] [Related]

  • 25. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide.
    Schaeren-Wiemers N, van der Bijl P, Schwab ME.
    J Neurochem; 1995 Nov 01; 65(5):2267-78. PubMed ID: 7595516
    [Abstract] [Full Text] [Related]

  • 26. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
    Seiwa C, Kojima-Aikawa K, Matsumoto I, Asou H.
    J Neurosci Res; 2002 Aug 01; 69(3):305-17. PubMed ID: 12125072
    [Abstract] [Full Text] [Related]

  • 27. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide.
    Dupree JL, Coetzee T, Suzuki K, Popko B.
    J Neurocytol; 1998 Sep 01; 27(9):649-59. PubMed ID: 10447239
    [Abstract] [Full Text] [Related]

  • 28. Myelin galactolipid synthesis in different strains of mice.
    Sato C, Yu RK.
    J Neurochem; 1987 Oct 01; 49(4):1069-74. PubMed ID: 3625200
    [Abstract] [Full Text] [Related]

  • 29. New perspectives on the function of myelin galactolipids.
    Coetzee T, Suzuki K, Popko B.
    Trends Neurosci; 1998 Mar 01; 21(3):126-30. PubMed ID: 9530920
    [Abstract] [Full Text] [Related]

  • 30. Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
    Yin W, Hu B.
    Exp Neurol; 2014 Jan 01; 251():72-83. PubMed ID: 24262204
    [Abstract] [Full Text] [Related]

  • 31. Lead alters the developmental profile of the galactolipid metabolic enzymes in cultured oligodendrocyte lineage cells.
    Deng W, Poretz RD.
    Neurotoxicology; 2001 Aug 01; 22(4):429-37. PubMed ID: 11577801
    [Abstract] [Full Text] [Related]

  • 32. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination.
    Ye P, Li L, Lund PK, D'Ercole AJ.
    Brain Res Dev Brain Res; 2002 Jun 30; 136(2):111-21. PubMed ID: 12101028
    [Abstract] [Full Text] [Related]

  • 33. High cholesterol level is essential for myelin membrane growth.
    Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA.
    Nat Neurosci; 2005 Apr 30; 8(4):468-75. PubMed ID: 15793579
    [Abstract] [Full Text] [Related]

  • 34. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice.
    Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR.
    J Neurosci; 2005 Feb 09; 25(6):1354-65. PubMed ID: 15703389
    [Abstract] [Full Text] [Related]

  • 35. Myelination in the absence of galactolipids and proteolipid proteins.
    Coetzee T, Suzuki K, Nave KA, Popko B.
    Mol Cell Neurosci; 1999 Jul 09; 14(1):41-51. PubMed ID: 10433816
    [Abstract] [Full Text] [Related]

  • 36. The number of cells expressing the myelin-supporting oligodendrocyte marker PLP-exon 3b remains unchanged in Wallerian degeneration.
    Li G, Blakemore WF.
    J Neurotrauma; 2004 Aug 09; 21(8):1044-9. PubMed ID: 15319003
    [Abstract] [Full Text] [Related]

  • 37. Myelin protein composition is altered in mice lacking either sulfated or both sulfated and non-sulfated galactolipids.
    Fewou SN, Fernandes A, Stockdale K, Francone VP, Dupree JL, Rosenbluth J, Pfeiffer SE, Bansal R.
    J Neurochem; 2010 Feb 09; 112(3):599-610. PubMed ID: 19878436
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain.
    Deng W, Poretz RD.
    Toxicol Appl Pharmacol; 2001 Apr 15; 172(2):98-107. PubMed ID: 11298496
    [Abstract] [Full Text] [Related]

  • 40. Leukemia/lymphoma-related factor regulates oligodendrocyte lineage cell differentiation in developing white matter.
    Dobson NR, Moore RT, Tobin JE, Armstrong RC.
    Glia; 2012 Sep 15; 60(9):1378-90. PubMed ID: 22615173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.